Skip to main content
Premium Trial:

Request an Annual Quote

Martha Trela, Timothy Mayleben, Maclyn McCarty, and Gregory Schiffman

Premium

Martha Trela has joined Affymetrix in a sales and marketing position. She comes to Affymetrix from Applied Biosystems, where she had served as vice president for worldwide marketing programs and communications.


Timothy Mayleben has joined the board of directors of Rubicon Genomics, replacing Richard Sloan, the Ann Arbor, Mich.-based company said last week. Most recently, he was COO and CFO of Esperion Therapeutics, which was recently acquired by Pfizer.


Maclyn McCarty, who co-discovered that genes consist of DNA, died on Jan. 2, Rockefeller University said last week. Together with Oswald Avery and Colin MacLeod, McCarty showed in the 1940s that DNA, not proteins, carry genetic information. McCarty received a Special Achievement in Medical Science award from the Lasker Foundation in 1994. He was 93.


Affymetrix CFO Gregory Schiffman was elected to the board of directors of Xenogen. He also will serve on the firm’s audit committee.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.